<![CDATA[Regulatory Voices]]>Regulatory Voices shares real conversations from across Regulatory Affairs in Pharma & Biotech covering careers, strategy, and the realities of the role. Built for professionals at every stage to learn, connect, and engage with the regulatory community. Powered by Codon Partners, US Life Science Staffing, Hosted by Conner Harman, Regulatory Affairs Recruitment Specialist

]]>https://podcasters.spotify.com/pod/show/conner29Riverside.fm (https://riverside.com)Sat, 25 Apr 2026 14:42:58 GMTThu, 16 Apr 2026 11:12:48 GMT60Hosted by Conner Harman - Powered by Codon Partners<p>Regulatory Voices shares real conversations from across Regulatory Affairs in Pharma &amp; Biotech covering careers, strategy, and the realities of the role. Built for professionals at every stage to learn, connect, and engage with the regulatory community. Powered by Codon Partners, US Life Science Staffing, Hosted by Conner Harman, Regulatory Affairs Recruitment Specialist</p>episodicHosted by Conner Harman - Powered by Codon Partnersnick.radoux@codon-partners.comno<![CDATA[Nicolas James - Episode 2 - Regulatory Voices]]>Thank you for joining us for the next episode of Regulatory Voices featuring Nicolas James, PharmD, MBA . Nic began his career as a pharmacist, including time spent working in a psychiatric hospital, before transitioning into regulatory affairs. Since then, he has built experience across big pharma, small biotech, and been is an acquisition environment and kept on too, giving him a well rounded perspective on how regulatory actually operates in practice and how much your career can change in environment in just a 6 year time frame. In this episode, we break down what regulatory strategy really means.

Not just following guidance, but interpreting it, making decisions in uncertain environments, and learning how to operate in the grey areas that define modern drug development. A key theme throughout is that you can read all the guidance documents you want, but real understanding comes from experience, judgment, and the people around you. We also explore the differences between large and small organisations, what changes during an acquisition, and how to think about building a career in regulatory today.

Finally, we take a deeper look at the psychiatric space. Drawing from his early experience and current work, Nic shares a grounded perspective on the unmet need that still exists, the challenges in developing new treatments, and where the field is heading, including the shift towards more personalised, data driven approaches. This session is ideal for anyone working in, or looking to move into, regulatory affairs who wants a practical, honest view of the role. Thank you again Nic for joining!

Links to other platforms to follow, full written report to go up tomorrow morning. If you enjoyed what you see today, please comment, like and share! Any questions for Nic or Me, put in the comments. If you would like to be apart of the show in the future please reach out me.

]]>9f9674c2-ba74-472c-9a76-cda893aaf806Tue, 21 Apr 2026 12:53:27 GMT<p>Thank you for joining us for the next episode of Regulatory Voices featuring Nicolas James, PharmD, MBA . Nic began his career as a pharmacist, including time spent working in a psychiatric hospital, before transitioning into regulatory affairs. Since then, he has built experience across big pharma, small biotech, and been is an acquisition environment and kept on too, giving him a well rounded perspective on how regulatory actually operates in practice and how much your career can change in environment in just a 6 year time frame. In this episode, we break down what regulatory strategy really means.</p><p></p><p>Not just following guidance, but interpreting it, making decisions in uncertain environments, and learning how to operate in the grey areas that define modern drug development. A key theme throughout is that you can read all the guidance documents you want, but real understanding comes from experience, judgment, and the people around you. We also explore the differences between large and small organisations, what changes during an acquisition, and how to think about building a career in regulatory today. </p><p></p><p>Finally, we take a deeper look at the psychiatric space. Drawing from his early experience and current work, Nic shares a grounded perspective on the unmet need that still exists, the challenges in developing new treatments, and where the field is heading, including the shift towards more personalised, data driven approaches. This session is ideal for anyone working in, or looking to move into, regulatory affairs who wants a practical, honest view of the role. Thank you again Nic for joining! </p><p></p><p>Links to other platforms to follow, full written report to go up tomorrow morning. If you enjoyed what you see today, please comment, like and share! Any questions for Nic or Me, put in the comments. If you would like to be apart of the show in the future please reach out me. </p>no00:42:3312Nicolas James - Episode 2 - Regulatory Voicesfull<![CDATA[Huong Huynh - Episode 1 - Regulatory Voices]]>Happy to be sharing the first entry in Regulatory Voices where I am joined by Huong Huynh, Director of Regulatory Science at Critical Path Institute.

In this first episode we talk about her time in the FDA and some of the mentality in Public Service vs Industry, we then dig deeper into what exactly is Regulatory Intelligence. We also take a deeper dive into the importance of Data Sharing, especially in the Rare Disease space utilising Non Profit Data Repositories.

Finally we look at RWE and how AI is currently being used for research and providing regulatory insights, a key theme when using AI is to "Trust but Verify" a common phrase I am hearing more and more.

Massive thank you to all who supported so far, if you have any questions for myself or Huong, feel free to comment below or message directly.

If you would like to be on the platform, reach out and lets talk about what your passionate about.

This interview and community is brought to you by Codon Partners, Life Science Staffing Agency, hosted by Conner Harman, a Pharma & Biotech Regulatory Affairs Specialist Recruiter

]]>https://podcasters.spotify.com/pod/show/conner29/episodes/Huong-Huynh---Episode-1---Regulatory-Voices-e3hv89q3490341b-9afc-4941-a029-1c76ae88fff9Wed, 15 Apr 2026 18:25:38 GMT<p>Happy to be sharing the first entry in Regulatory Voices where I am joined by Huong Huynh, Director of Regulatory Science at Critical Path Institute. </p><p>In this first episode we talk about her time in the FDA and some of the mentality in Public Service vs Industry, we then dig deeper into what exactly is Regulatory Intelligence. We also take a deeper dive into the importance of Data Sharing, especially in the Rare Disease space utilising Non Profit Data Repositories. </p><p>Finally we look at RWE and how AI is currently being used for research and providing regulatory insights, a key theme when using AI is to "Trust but Verify" a common phrase I am hearing more and more. </p><p>Massive thank you to all who supported so far, if you have any questions for myself or Huong, feel free to comment below or message directly. </p><p>If you would like to be on the platform, reach out and lets talk about what your passionate about. </p><p>This interview and community is brought to you by Codon Partners, Life Science Staffing Agency, hosted by Conner Harman, a Pharma &amp; Biotech Regulatory Affairs Specialist Recruiter</p> no00:45:3511Huong Huynh - Episode 1 - Regulatory Voicesfull